Skip to main content
Log in

CESAR support ECMO over conventional ventilatory support

  • News item
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

REFERENCE

  1. Peek GJ, Mugford M, Tiruvoipati R, Wilson A, Allen E, Thalanany MM, Hibbert CL, Truesdale A, Clemens F, Cooper N, Firmin RK, Elbourne D, CESAR trial collaboration.Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial. Lancet 374: 1351-1363, No. 9698, 17 Oct 2009

  2. Zwischenberger JB, Lynch JE.Will CESAR answer the adult ECMO debate? Lancet 374: 1307-1308, No. 9698, 17 Oct 2009

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

CESAR support ECMO over conventional ventilatory support. Pharmacoecon. Outcomes News 588, 4 (2009). https://doi.org/10.2165/00151234-200905880-00005

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200905880-00005

Keywords

Navigation